▶ 調査レポート

HIV/AIDS診断の世界市場:製品別、テスト別、エンドユーザー別

• 英文タイトル:HIV/AIDS Diagnostics Market (Product: Kits & Reagents and Instruments; Test: Nucleic Acid Tests, Rapid Tests (POC), ELISA, and Others; End User: Hospitals, Diagnostic Laboratories, Academic & Research Institutes, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

HIV/AIDS Diagnostics Market (Product: Kits & Reagents and Instruments; Test: Nucleic Acid Tests, Rapid Tests (POC), ELISA, and Others; End User: Hospitals, Diagnostic Laboratories, Academic & Research Institutes, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027「HIV/AIDS診断の世界市場:製品別、テスト別、エンドユーザー別」(市場規模、市場予測)調査レポートです。• レポートコード:TPM-NV032
• 出版社/出版日:Transparency Market Research / 2019年9月
• レポート形態:英文、PDF、202ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥799,710 (USD5,795)▷ お問い合わせ
  Multi User¥1,213,710 (USD8,795)▷ お問い合わせ
  Global Site License¥1,627,710 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、HIV/AIDS診断の世界市場について調べ、HIV/AIDS診断の世界市場規模、市場動向、市場シェア、市場環境、市場予測、製品別(キット&試薬および機器)分析、テスト別(核酸テスト、ラピッドテスト(POC)、ELISA、その他)分析、エンドユーザー別(病院、診断研究所、学術研究機関、その他)分析、関連企業情報などをまとめました。
・HIV/AIDS診断の市場概要
・HIV/AIDS診断の市場動向
・HIV/AIDS診断の世界市場規模・予測
・HIV/AIDS診断市場:製品別(キット&試薬および機器)
・HIV/AIDS診断市場:テスト別(核酸テスト、ラピッドテスト(POC)、ELISA、その他)
・HIV/AIDS診断市場:テスト別(核酸テスト、ラピッドテスト(POC)、ELISA、その他)
・地域別分析(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争環境・関連企業分析

HIV/AIDS Diagnostics Market – Scope of the Report

[202 Pages Report] A new study on the global HIV/AIDS diagnostics market was published by Transparency Market Research (TMR). It presents a wealth of information on key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the HIV/AIDS diagnostics market. TMR’s study offers important information about the HIV/AIDS diagnostics market, to demonstrate how growth will discern during the forecast period of 2019–2027. The HIV/AIDS diagnostics market analysis also gives a detailed understanding of the key trends and developments made by major players in the market.

Key drivers of market growth, which elucidate value chain as well as supply chain analysis and Compound Annual Growth Rate (CAGR), are mentioned in TMR’s study in a comprehensive manner. This data can help stakeholders interpret the quantitative growth aspects of the HIV/AIDS diagnostics market during the forecast period.

An extensive analysis on leading market players’ business strategies is also featured in TMR’s study on the HIV/AIDS diagnostics market. This can help readers understand principal factors to foresee growth in the HIV/AIDS diagnostics market. In this study, readers can also find specific data on the qualitative and quantitative growth avenues for the HIV/AIDS diagnostics market, which will guide market players in making informed decisions in the future.

Key Questions Answered in TMR’s HIV/AIDS Diagnostics Market Study

What is the scope of growth for the HIV/AIDS diagnostics market in the rapid tests (POC) landscape?
Will North America continue to remain the most profitable regional market for HIV/AIDS diagnostics providers?
What will be the Y-o-Y growth of the HIV/AIDS diagnostics market between 2019 and 2027?
Which are the leading companies in the global HIV/AIDS diagnostics market?
What is the influence of the changing trends in technologies for the ELISA test in the HIV/AIDS diagnostics landscape?
Which factors will impede the growth of the HIV/AIDS diagnostics market during the forecast period?
Research Methodology

A unique research methodology is utilized by TMR to conduct a comprehensive research on the growth of the HIV/AIDS diagnostics market, and to arrive at conclusions on the future growth prospects of the market. This research methodology is a consolidation of primary and secondary research, which helps analysts justify the accuracy and authenticity of the drawn conclusions.

Secondary resources referred by to analysts during the production of the HIV/AIDS diagnostics market report include statistics from company annual reports, World Bank database, company websites, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence consultants, who contributed to the production of TMR’s study on the HIV/AIDS diagnostics market, as a primary resource.

These primary and secondary resources provided exclusive information during the interviews, which serves as a validation from HIV/AIDS diagnostics industry leaders. Access to an extensive internal repository and external proprietary databases allows for this report to address specific details and questions about the HIV/AIDS diagnostics market with accuracy. The study also uses a top-down approach to assess the numbers for each segment, and a bottom-up approach to counter-validate them. This has helped in making TMR’s estimates on the future prospects of the HIV/AIDS diagnostics market more reliable and accurate.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Infection Prevention Devices Market

4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global HIV/AIDS Diagnostics Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
5.1. HIV Disease Epidemiology
5.2. Technological Advancements
5.3. Key Mergers & Acquisitions

6. Global HIV/AIDS Diagnostics Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product, 2017–2027
6.3.1. Kits and Reagents
6.3.2. Instruments

7. Global HIV/AIDS Diagnostics Market Analysis and Forecasts, by Test
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Test, 2017–2027
7.3.1. Nucleic Acid Tests
7.3.2. Rapid Tests (POC)
7.3.3. ELISA
7.3.4. Others
7.4. Market Attractiveness, by Test

8. Global HIV/AIDS Diagnostics Market Analysis and Forecasts, by End User
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End User, 2017–2027
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Academic and Research Institutes
8.3.4. Others
8.4. Market Attractiveness, by End User

9. Global HIV/AIDS Diagnostics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia-Pacific
9.2.4. . Latin America
9.2.5. Middle East and Africa
9.3. Market Attractiveness, by Country/Region

10. North America HIV/AIDS Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2027
10.2.1. Kits and Reagents
10.2.2. Instruments
10.3. Market Value Forecast, by Test, 2017–2027
10.3.1. Nucleic Acid Tests
10.3.2. Rapid Tests (POC)
10.3.3. ELISA
10.3.4. Others
10.4. Market Value Forecast, by End User, 2017–2027
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories
10.4.3. Academic and Research Institutes
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Test
10.6.3. By End User
10.6.4. By Country

11. Europe HIV/AIDS Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2027
11.2.1. Kits and Reagents
11.2.2. Instruments
11.3. Market Value Forecast, by Test, 2017–2027
11.3.1. Nucleic Acid Tests
11.3.2. Rapid Tests (POC)
11.3.3. ELISA
11.3.4. Others
11.4. Market Value Forecast, by End User, 2017–2027
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories
11.4.3. Academic and Research Institutes
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Test
11.6.3. By End User
11.6.4. By Country/Sub-region

12. Asia Pacific HIV/AIDS Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2027
12.2.1. Kits and Reagents
12.2.2. Instruments
12.3. Market Value Forecast, by Test, 2017–2027
12.3.1. Nucleic Acid Tests
12.3.2. Rapid Tests (POC)
12.3.3. ELISA
12.3.4. Others
12.4. Market Value Forecast, by End User, 2017–2027
12.4.1. Hospitals
12.4.2. Diagnostic Laboratories
12.4.3. Academic and Research Institutes
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Test
12.6.3. By End User
12.6.4. By Country/Sub-region

13. Latin America HIV/AIDS Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2027
13.2.1. Kits and Reagents
13.2.2. Instruments
13.3. Market Value Forecast, by Test, 2017–2027
13.3.1. Nucleic Acid Tests
13.3.2. Rapid Tests (POC)
13.3.3. ELISA
13.3.4. Others
13.4. Market Value Forecast, by End User, 2017–2027
13.4.1. Hospitals
13.4.2. Diagnostic Laboratories
13.4.3. Academic and Research Institutes
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Test
13.6.3. By End User
13.6.4. By Country/Sub-region

14. Middle East & Africa HIV/AIDS Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2027
14.2.1. Kits and Reagents
14.2.2. Instruments
14.3. Market Value Forecast, by Test, 2017–2027
14.3.1. Nucleic Acid Tests
14.3.2. Rapid Tests (POC)
14.3.3. ELISA
14.3.4. Others
14.4. Market Value Forecast, by End User, 2017–2027
14.4.1. Hospitals
14.4.2. Diagnostic Laboratories
14.4.3. Academic and Research Institutes
14.4.4. Others
14.5. Market Value Forecast, by Country, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Test
14.6.3. By End User
14.6.4. By Country/Sub-region

15. Company Profiles
15.1. Market Share Analysis, by Company, 2018
15.2. Company Profiles
15.2.1. Hologic, Inc.
15.2.2. Abbott
15.2.3. Bio-Rad Laboratories
15.2.4. F. Hoffmann-La Roche Ltd.
15.2.5. OraSure Technologies, Inc.
15.2.6. Siemens Healthineers
15.2.7. Chembio Diagnostic Systems
15.2.8. Danaher Corporation
15.2.9. Becton, Dickinson and Company
15.2.10. Other Prominent Players

*Note: Financial details for companies that do not report this information in public domain might not be captured.

List of Tables

Table 1 Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027
Table 2 Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test, 2017–2027
Table 3 Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End User, 2017–2027
Table 4 Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017–2027
Table 5 North America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027
Table 6 North America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test, 2017–2027
Table 7 North America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End User, 2017–2027
Table 8 North America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2027
Table 9 Europe HIV/AIDS Diagnostics Market Revenue (US$ Mn) Forecast, by Product Type, 2017–2027
Table 10 Europe HIV/AIDS Diagnostics Market Revenue (US$ Mn) Forecast, by Test, 2017–2027
Table 11 Europe HIV/AIDS Diagnostics Market Revenue (US$ Mn) Forecast, by End User, 2017–2027
Table 12 Europe HIV/AIDS Diagnostic Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 13 Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027
Table 14 Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test, 2017–2027
Table 15 Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End User, 2017–2027
Table 16 Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 17 Latin America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027
Table 18 Latin America HIV/AIDS Diagnostics Market Revenue (US$ Mn) Forecast, by Test, 2017–2027
Table 19 Latin America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End User, 2017–2027
Table 20 Latin America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21 Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027
Table 22 Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test, 2017–2027
Table 23 Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End User, 2017–2027
Table 24 Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027